DRIO - צמיחת הכנסות ב-12 חודשים נגררים DarioHealth Inc

לוגו של חברה ציבורית DarioHealth Inc (DRIO)

The annual change in sales volume for LTM demonstrates the current level of the -14.00 metric for DarioHealth Corp. (DRIO). Revenue stability is driven by consistent demand for hypertension and diabetes monitoring, rendering the business crisis-resistant. ARR growth is supported by the implementation of AI services and B2B deals. DarioHealth Corp. (DRIO) successfully competes with tech giants by integrating digital platforms directly into the insurance programs of major US employers.

DRIO DarioHealth Corp: צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים בטווח 11.02.2024 - 18.11.2026

DarioHealth (DRIO) - פילוחי מדדים ודוחות פיננסיים

הערכת שווי פונדמנטלית של החברה:DarioHealth Corporation
דוגמת מוצר של mydario.com

For DarioHealth Corp. (DRIO), sales expansion rates depend directly on B2B sales efficiency amid intense pricing pressure. This indicator measures the percentage change in revenue over a rolling 12-month period, neutralizing quarterly seasonality. Analyzing the year-over-year revenue dynamics for the last 12 months, an investor sees the current value of -14.00. A decline in this metric may signal excessive discounting when securing corporate contracts, while stable growth confirms the resilience of the digital health business model.